Regulation of immunities induce by GVHD, HVGD with cytokine abnormalities

细胞因子异常的 GVHD、HVGD 诱导的免疫调节

基本信息

  • 批准号:
    06670499
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

It is well known that GVHD and HVGD are severe complications after transplantation tharapy for immunotherapies, we recently established a murine model of BMT-GVHD that was induced by the injection of parental bone marrow cells plus spleen cells as a source of T cells into irradiated F1 recipients.We found that increased serum IgE and IgG1 levels were correlated with BMT-GVHD such as liver disease and splenomegaly. The allotype of increased IgE levels in BMT-GVHD was IgE^a of donor origin, not IgE^b of host origin. We also found that in the thymus of murine BMT-GVHD, the CD4^+ CD8^+ double positive (DP) T cells were decreased, but the CD4^+ CD8^- or CD4^- CD8^+ single positive (SP) T cells were increased. When the recipients were treated with anti-IL-4 antibody (11B11), the increase of IgE and IgG1 was markedly reduced and liver disease and splenomegaly were also prevented. Moreover, abnormal T cell differentiation and maturation were suppressed. These observations suggest that IL-4 plays an important role in immunoregulation or pathogenesis of allogeneic effects and 11B11 prevents immunodysfunction including T cell differentiaiton in the thymus or the spleen and autoimmune symptoms in murine BMT-GVHD.
移植物抗宿主病(GVHD)和HVGD是移植术后的严重并发症,近年来,我们建立了一种小鼠骨髓移植物抗宿主病(BMT-GVHD)模型,用骨髓细胞和脾细胞作为T细胞来源,对F1受者进行照射,发现血清IgE和IgG_1水平升高与BMT-GVHD(如肝脏疾病和脾肿大)有关。BMT-GVHD中IgE水平升高的同种异型是供体来源的IgE^a,而不是宿主来源的IgE^B。在BMT-GVHD小鼠胸腺中,CD 4 ^+ CD 8 ^+双阳性(DP)T细胞减少,而CD 4 ^+ CD 8 ^-或CD 4 ^-CD 8 ^+单阳性(SP)T细胞增加。当接受抗IL-4抗体(11B 11)治疗时,IgE和IgG 1的增加明显减少,肝脏疾病和脾肿大也得到了预防。此外,异常的T细胞分化和成熟被抑制。这些观察结果表明,IL-4在同种异体效应的免疫调节或发病机制中起重要作用,11 B11预防免疫功能障碍,包括胸腺或脾脏中的T细胞分化和鼠BMT-GVHD中的自身免疫症状。

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ushiyama, C.: "Anti-IL-4 antibody preveents a Graft-versus-Host diseases (GVHD) in mice after bone marrow transplantation (BMT) : IgE allotype is an important marker of GVHD." J.Immunol. 154. 2687-2696 (1995)
Ushiyama, C.:“抗 IL-4 抗体可预防骨髓移植 (BMT) 后小鼠的移植物抗宿主病 (GVHD):IgE 同种异型是 GVHD 的重要标志物。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
USui M.: "Construction of a monoclonal antibody to Igh-7a." Immunogenetics. 37. 301-304 (1993)
USui M.:“Igh-7a 单克隆抗体的构建。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ushiyama,C: "Anti-IL-4 antibody prevents a Graft-versus-Host diseaes (GVHD) in mice after bone marrow transplantation (BMT) : IgE allotype is an important marker of GVHD." J. Immunol.154. 2687-2696 (1995)
Ushiyama,C:“抗 IL-4 抗体可预防骨髓移植 (BMT) 后小鼠的移植物抗宿主病 (GVHD):IgE 同种异型是 GVHD 的重要标志物。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
C.Ushiyama et al.: "Anti-IL-4 antibody prevents a Graft-versus-Host Desease(GVHD)in mice after bone marrow transplntation (BMT):IgE allotype is an important marker of GVHD." J.Immunol.(in press). (1995)
C.Ushiyama 等人:“抗 IL-4 抗体可预防骨髓移植 (BMT) 后小鼠的移植物抗宿主病 (GVHD):IgE 同种异型是 GVHD 的重要标志物。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Yamada et al.: "Construction of a monoclonal antibody against Igh-7b." Immunogenetics.40. 296-299 (1994)
M.Yamada 等人:“抗 Igh-7b 的单克隆抗体的构建。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HIRANO Takao其他文献

HIRANO Takao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HIRANO Takao', 18)}}的其他基金

Noninvasive measurement of advanced glycation end product level to predict the curative effect of diabetic macular edema
无创测量晚期糖基化终末产物水平预测糖尿病黄斑水肿的疗效
  • 批准号:
    15K20252
  • 财政年份:
    2015
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Differential effects of anti Fas ligand and MPI on GVHD pathologies
抗 Fas 配体和 MPI 对 GVHD 病理的不同影响
  • 批准号:
    12557084
  • 财政年份:
    2000
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of adhesion molecules on mast cells
肥大细胞上粘附分子的分析
  • 批准号:
    05044187
  • 财政年份:
    1993
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
サイトカインによるIgE抑御機構にもとずくI型アレルギー疾患治療への試み
基于细胞因子IgE抑制机制治疗I型过敏性疾病的尝试
  • 批准号:
    03670336
  • 财政年份:
    1991
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Detection of antiglycolipid antibody in the sera from the patients with autoimmune diseases
自身免疫性疾病患者血清中抗糖脂抗体的检测
  • 批准号:
    62570298
  • 财政年份:
    1987
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了